Anti-proliferative effect of Jesridonin on paclitaxel-resistant EC109 human esophageal carcinoma cells

Chemoresistance to anticancer drugs is a major obstacle in the efforts to develop a successful treatment strategy for esophageal squamous carcinoma (ESCC). Thus, the exploration of new drugs and treatment strategies for combating resistance are of utmost importance. In this study, we investigated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Cong, Guo, Liubin, Wang, Saiqi, Wang, Junwei, Li, Yongmei, Dou, Yinhui, Wang, Ran, Shi, Hongge, Ke, Yu, Liu, Hongmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360389/
https://www.ncbi.nlm.nih.gov/pubmed/28204832
http://dx.doi.org/10.3892/ijmm.2017.2867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360389/
https://www.ncbi.nlm.nih.gov/pubmed/28204832
http://dx.doi.org/10.3892/ijmm.2017.2867

Ejemplares similares